The biotechnology industry.
Biotech earnings season is the quarterly window, clustered in late January, April, July, and October, when listed companies report revenue, profit or loss, and pipeline progress for the closed quarter. Roche reported nine-month sales up 7% at constant exchange rates on October 23, 2025; Novartis…
Biologics manufacturing is the production of medicines made by living cells rather than by chemical synthesis: master cell bank, large-scale culture, multi-step purification, sterile filling. Monoclonal antibody production in Chinese hamster ovary cells is described in the literature as a…
A biotech licensing deal is a risk-transfer contract built from four standard components: an upfront payment, milestone payments tied to development and sales events, tiered royalties on net sales, and sometimes equity. IMPACT Therapeutics licensed senaparib to Pharmanovia for up to 423.5…
A contract research organization is a company that performs research and development services for sponsors on a contractual basis, and its center of gravity is the clinical trial: site selection, monitoring, data management, statistics, and regulatory filings. The industry's rise was rapid, as a…
Biotech financing is staged risk transfer: venture rounds fund value-creating milestones until a listing or sale clears at a higher price, and each stage re-prices the company against evidence rather than revenue. The machinery is standard — preferred stock, tranches, lock-ups — and it is…